about
Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppressionImmune Cells in Cancer Therapy and Drug DeliveryNatural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer ImmunotherapyOverview of current immunotherapeutic strategies for gliomaAlloreactive Natural Killer Cells for the Treatment of Acute Myeloid Leukemia: From Stem Cell Transplantation to Adoptive ImmunotherapyTumor-primed NK cells: waiting for the green lightModulation of NK cell function by genetically coupled C-type lectin-like receptor/ligand pairs encoded in the human natural killer gene complexIntra- and Extra-Cellular Events Related to Altered Glycosylation of MUC1 Promote Chronic Inflammation, Tumor Progression, Invasion, and MetastasisThe Janus Face of Death Receptor Signaling during Tumor ImmunoeditingInnate lymphoid cell regulation of adaptive immunityDysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor ImmunityKita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafishMicroenvironmental regulation of metastasisBystander cells enhance NK cytotoxic efficiency by reducing search time.Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.Cancer and physical activity.Tumor-associated, estrogen receptor-related antigen EBAG9: linking intracellular vesicle trafficking, immune homeostasis, and malignancy.Inhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.hrHPV E5 oncoprotein: immune evasion and related immunotherapies.Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model.Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype.NK cell-based immunotherapy for malignant diseases.Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.Loss of expression of MHC class I-related chain A (MICA) is a frequent event and predicts poor survival in patients with hepatocellular carcinoma.Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.A novel anti-CEACAM5 monoclonal antibody, CC4, suppresses colorectal tumor growth and enhances NK cells-mediated tumor immunity.Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.Tumor-associated autoantibodies as diagnostic and prognostic biomarkers.Ab-IL2 fusion proteins mediate NK cell immune synapse formation by polarizing CD25 to the target cell-effector cell interface.Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implicationsLack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytesCharacterization of NCR1+ cells residing in lymphoid tissues in the gut of lambs indicates that the majority are NK cells.Big opportunities for small molecules in immuno-oncology.Agonist antibody that induces human malignant cells to kill one another.Expansion of CD16-negative natural killer cells in the peripheral blood of patients with metastatic melanoma.IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function.CD200 expression suppresses natural killer cell function and directly inhibits patient anti-tumor response in acute myeloid leukemiaAssociation between inflammatory infiltrates and isolated monosomy 22/del(22q) in meningiomasMHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell lines
P2860
Q21089831-3B675779-DE51-4D49-B969-AFE1910B393FQ26747061-FF480C85-87FD-487E-86BF-29CA759764A7Q26772347-5AB56D4E-0DA3-4D07-A1E2-0E95DF0BF67CQ26776345-4E8D88D9-6362-4B90-A87F-991AF5FF6DC7Q26777209-045545AE-0B06-499B-9D2F-AD0D580643EAQ26999306-33CD7299-68BF-4552-8AF4-9CC343C541FFQ27001661-7DC57B29-C14F-45ED-B0C0-85C315080EB3Q28066445-A3C02E31-3830-4132-B42D-665135299408Q28070036-3DADBCFA-ED44-45B1-A185-72825D19D004Q28072425-B00A972B-00EE-4381-8396-34301906A47FQ28075996-B0653656-DDAA-4C64-883D-59E6864D64C1Q28476492-587FB892-1277-443C-9087-21A8768355F1Q29547660-EAD2CDF1-AA6A-4C58-8E60-6FDA08886E2EQ30841600-0575F881-D6C1-4146-B48C-5A2086B926CDQ33468660-F69DC2D2-9357-4251-963E-211C100631C2Q33608369-59795059-5C68-4EB3-8AD0-41E79FE08424Q33655825-79CDA558-B6AC-4187-A211-4F08D5E89890Q33698116-E603BA7D-9CAB-43D3-BF20-706B0A4CB048Q33730462-122AE060-7B04-4973-A0DC-94AB43250BFEQ33765161-6533B48C-7A68-4C07-842C-904FC7898930Q33767021-56BE3D35-63BE-43B6-BCE0-50DC8057C2D9Q33827433-7B957221-4799-4D35-9470-638C4CB09CEFQ33839054-E8742D39-90A3-439E-9F38-B84564F3A521Q33873686-61E70140-1D45-4316-A6C4-4AA6C58FA64BQ33898809-DEA66457-32BB-49C9-B3D3-65BBF891CC52Q33917198-185D5566-4F65-492C-B13D-47D58E88B8FFQ33952198-33C06251-BF62-4CDA-B497-4BE168984A2BQ34016504-582648BA-54EB-44B9-ABE9-5915A3FB3733Q34049184-33C4E1E4-8A1F-466F-BB61-765B6E490055Q34129154-992630FC-78B8-4E74-98E2-F0506284A756Q34153620-26EEDF24-5078-4749-83F9-25AE69C20C9EQ34166565-55E8BC85-6A1C-4FE4-802F-A061C75B63AAQ34248448-8050B023-CCF6-4DA0-BFE4-BEFBA9ED66AEQ34487689-5AB46822-6372-4A5D-ABA7-8A2C81C34BDAQ34498809-38AB7CC4-2BC8-4728-956F-C25EBFE30EF1Q34627004-9E3EBF19-B577-4AF7-A5EB-9C44C18F235FQ34755351-69876ACC-A516-4DC2-A814-35FF5EB0EA59Q34977414-37A8639E-D59A-4015-879B-AB33B121A951Q35008994-7B5F8AED-8FBB-4EC5-99E4-387EAC6FCD8CQ35061364-8BF70D30-9B42-476F-A107-4997D31F004E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
gotara zanistî
@ku-latn
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
name
NK cells and cancer immunosurveillance.
@en
NK cells and cancer immunosurveillance.
@nl
type
label
NK cells and cancer immunosurveillance.
@en
NK cells and cancer immunosurveillance.
@nl
prefLabel
NK cells and cancer immunosurveillance.
@en
NK cells and cancer immunosurveillance.
@nl
P2860
P356
P1433
P1476
NK cells and cancer immunosurveillance
@en
P2093
I Waldhauer
P2860
P2888
P304
P356
10.1038/ONC.2008.267
P407
P577
2008-10-01T00:00:00Z